Natural Sleep and Drug-induced Sleep Endoscopy
Comparison Between Natural Sleep Endoscopy and Drug-induced Sleep Endoscopy Among Obstructive Sleep Apnea Subjects Referred for Surgical Treatment
1 other identifier
interventional
28
1 country
1
Brief Summary
Drug induced sleep endoscopy (DISE) has been performed worldwide since 1991 to determine the site and configuration of upper airway obstruction in patients with obstructive sleep apnea (OSA). However, there are no studies comparing DISE to sleep endoscopy during natural sleep. Objectives: To compare DISE to natural sleep endoscopy in OSA patients referred for surgical treatment. Methods: OSA patients referred to surgical treatment (lateral pharyngoplasty) will be enrolled in this study. Natural sleep endoscopy will be performed at the sleep lab during the night. Propofol induced sleep will be performed at the operating room before surgery. The VOTE (velum, oropharyngeal lateral walls, tongue base and epiglottis) classification will be used to compare site and configuration of collapse between studies. Peak inspiratory flow will also be compared between studies.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jan 2015
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2015
CompletedFirst Submitted
Initial submission to the registry
August 4, 2016
CompletedFirst Posted
Study publicly available on registry
December 28, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2018
CompletedJuly 31, 2018
July 1, 2018
2.9 years
August 4, 2016
July 29, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
The VOTE Endoscopic Classification
Comparison of site and configuration of endoscopy findings between the natural and drug-induced sleep endoscopy. The VOTE Endoscopic Classification describes the patterns and the degree of obstruction during sleep endoscopy.
Immediately, during the procedure
Secondary Outcomes (1)
Peak inspiratory flow
Immediately, during the procedure
Study Arms (2)
Natural Sleep
NO INTERVENTIONOSA subjects referred for surgical treatment will evaluated endoscopically during natural sleep
Propofol Induced Sleep
OTHERSleep endoscopy during propofol induced sleep OSA subjects referred for surgical treatment will be evaluated endoscopically during propofol induced sleep
Interventions
It will be performed a sleep endoscopy during drug induced sleep endoscopy
Eligibility Criteria
You may qualify if:
- BMI less than 35kg/m2
- Apnea-hypopnea index \> 5 events/hour of sleep
- Clinical indication of surgical treatment for sleep apnea
You may not qualify if:
- Severe or decompensated cardiac or respiratory diseases
- Previous pharyngeal surgery
- Tonsils grade III or IV
- Other sleep disturbance (parasomnias, primary insomnia, narcolepsy)
- Sedative medication use (opioids, benzodiazepines and muscle relaxants)
- Uncontrolled diabetes or hyperthyroidism
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Sleep Laboratory, Heart Institute, Pulmonary Division, Hospital das Clínicas da Universidade de São Paulo
São Paulo, São Paulo, 05403900, Brazil
Related Publications (1)
Ordones AB, Grad GF, Cahali MB, Lorenzi-Filho G, Sennes LU, Genta PR. Comparison of upper airway obstruction during zolpidem-induced sleep and propofol-induced sleep in patients with obstructive sleep apnea: a pilot study. J Clin Sleep Med. 2020 May 15;16(5):725-732. doi: 10.5664/jcsm.8334. Epub 2020 Feb 7.
PMID: 32029070DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Pedro R Genta, Post Doc
Sleep Laboratoy, Heart Institute
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
August 4, 2016
First Posted
December 28, 2016
Study Start
January 1, 2015
Primary Completion
December 1, 2017
Study Completion
January 1, 2018
Last Updated
July 31, 2018
Record last verified: 2018-07
Data Sharing
- IPD Sharing
- Will share